Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pohlman

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|September 18, 2007
Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphomaT Y Kang, L A Rybicki, B J Bolwell, et al.
Bone Marrow Transplantation|January 25, 2011
Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantationS Malik, B Bolwell, L Rybicki, et al.
Bone Marrow Transplantation|February 16, 2005
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemiaS S Farag, B J Bolwell, P J Elder, et al.
Bone Marrow Transplantation|August 20, 2008
400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantationR M Sobecks, R Dean, L A Rybicki, et al.
Bone Marrow Transplantation|August 12, 2014
Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantationM Tavadze, L Rybicki, S Mossad, et al.
Bone Marrow Transplantation|April 26, 2016
Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphomaS Hong, L Rybicki, D M Abounader, et al.
Bone Marrow Transplantation|October 11, 2016
GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignanciesA Nazha, L Rybicki, D Abounader, et al.
Bone Marrow Transplantation|May 16, 2000
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant GroupS N Wolff, J Fay, D Stevens, et al.
Bone Marrow Transplantation|October 19, 2004
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infectionR K Avery, B J Bolwell, B Yen-Lieberman, et al.
Bone Marrow Transplantation|July 21, 2015
Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantationS Fu, L Rybicki, D Abounader, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|September 18, 2007
Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphomaT Y Kang, L A Rybicki, B J Bolwell, et al.
Bone Marrow Transplantation|January 25, 2011
Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantationS Malik, B Bolwell, L Rybicki, et al.
Bone Marrow Transplantation|February 16, 2005
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemiaS S Farag, B J Bolwell, P J Elder, et al.
Bone Marrow Transplantation|August 20, 2008
400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantationR M Sobecks, R Dean, L A Rybicki, et al.
Bone Marrow Transplantation|August 12, 2014
Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantationM Tavadze, L Rybicki, S Mossad, et al.
Bone Marrow Transplantation|April 26, 2016
Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphomaS Hong, L Rybicki, D M Abounader, et al.
Bone Marrow Transplantation|October 11, 2016
GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignanciesA Nazha, L Rybicki, D Abounader, et al.
Bone Marrow Transplantation|May 16, 2000
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant GroupS N Wolff, J Fay, D Stevens, et al.
Bone Marrow Transplantation|October 19, 2004
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infectionR K Avery, B J Bolwell, B Yen-Lieberman, et al.
Bone Marrow Transplantation|July 21, 2015
Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantationS Fu, L Rybicki, D Abounader, et al.
Pageof 7